Dmitriy Dmitriy, MD

Hematology-Oncology, Icahn School of Medicine at Mount Sinai

Planning Committee

Financial Disclosure

Xencor, Memgen, BioInvent, Daiichi Sankyo, Gilead, Replimune, GSK, Eli Lilly

Consultant

Tikva Allocell, Calidi, OverT, Everest

Advisor

Xencor, Zymeworks, NextCure, Tubulis, Volastra Therapeutics

Contractor

NIH

Grant Or Contract

OverT, Calidi

Ownership Interest